Tivic Health Systems is a commercial-stage medical technology company that develops and markets non-drug, neuromodulation-based therapies for nasal and sinus health. The company’s solutions are designed to alleviate sinus pain, pressure and congestion through gentle microcurrent and vibration stimulation. By targeting the underlying nerve pathways in the nasal passages, Tivic Health aims to provide an alternative to over-the-counter and prescription medications without introducing systemic side effects.
The flagship product, ClearUP™ Sinus Pain Relief, is an FDA-cleared, hand-held device intended for home use. ClearUP employs a small, ergonomic applicator that is applied externally to designated points on the face for brief treatment sessions. Tivic Health has conducted clinical studies demonstrating significant reductions in sinus pain and congestion, and the device is rechargeable and portable to facilitate daily self-care routines.
Headquartered in northern California, Tivic Health Systems sells ClearUP directly to consumers via its e-commerce platform and through select retail and healthcare distribution partners. The company continues to expand its commercial footprint by forging alliances with pharmacies, online retailers and professional allergy and sinus care networks. While its initial focus has been the U.S. market, Tivic Health is evaluating opportunities for international expansion and additional product indications.
Founded in 2013, Tivic Health completed its initial public offering in October 2020 and is listed on the NASDAQ under the symbol TIVC. The company is led by a management team with deep experience in medical device development, clinical research and healthcare commercialization, all focused on bringing non-invasive therapeutic innovations to patients suffering from chronic sinus and nasal disorders.
